UK Stocks-Factors to watch on Sept 30

Sept 30 (Reuters) - Britain's FTSE 100 .FTSE index is seen opening 21 points higher on Thursday, according to financial bookmakers.

* MARKS & SPENCER: Marks & Spencer MKS.L pledged to become net zero in carbon emissions across its own operations, its entire supply chain and its products by 2040, 10 years ahead of a government target for Britain.

* ASTRAZENECA: AstraZeneca Plc's AZN.L COVID-19 vaccine demonstrated 74% efficacy at preventing symptomatic disease, according to long-awaited results of the company's U.S. clinical trial published on Wednesday.

* BOE: Bank of England Governor Andrew Bailey said on Wednesday that he expected Britain's economy to recover its pre-pandemic level of output early next year.

* G7: Finance ministers from the Group of Seven said they made some progress at reaching a joint position on a landmark global corporate tax deal.

* STAFF VISA: Britain's financial sector has called on the government to ease visa requirements on overseas staff who want to work up to six months in the country to maintain global competitiveness.

* DATA: British car production dropped by 27% year-on-year in August, a trade industry body said on Thursday.

* GOLD: Gold prices edged higher after hitting a seven-week trough in the previous session, although a robust dollar and elevated U.S. Treasury yields kept pressure intact.

* OIL: Oil prices fell, extending losses after official figures showed an unexpected rise in inventories in the United States although prices seem to have stabilised following a recent run of gains.

* London's FTSE 100 ended higher on Wednesday, as AstraZeneca boosted healthcare stocks on completing a takeover deal to sharpen its focus on rare-disease drugs.



FY results Avacta


HY results

* For more on the factors affecting European stocks, please click on:


> Financial Times

> Other business headlines

(Reporting By Geetha Panchaksharam)

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.